Immunocore Holdings plc (IMCR) ROA
- 2026-06-30: ROA -1.61%.
- 2026-03-31: ROA -2.57%.
- 2025-12-31: ROA -3.33%.
- 2025-09-30: ROA -2.65%.
Complete source-backed roa history.
- Available history
- 2022-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|---|
| 2026-06-30 | -1.61% |
| 2026-03-31 | -2.57% |
| 2025-12-31 | -3.33% |
| 2025-09-30 | -2.65% |
| 2025-06-30 | -1.88% |
| 2025-03-31 | -2.10% |
| 2024-12-31 | -5.06% |
| 2024-09-30 | -4.34% |
| 2024-06-30 | -5.36% |
| 2024-03-31 | -6.06% |
| 2023-12-31 | -9.26% |
Annual ROA
| Date | ROA |
|---|---|
| 2025-12-31 | -3.33% |
| 2024-12-31 | -5.06% |
| 2023-12-31 | -9.26% |
| 2022-12-31 | -9.97% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |